Related Experiment Video
Updated: Jan 3, 2026
09:02
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
22.2K
Targeted Therapy in Chronic Lymphocytic Leukemia.
Thomas J Kipps1, Michael Y Choi
1From the Moores Cancer Center, University of California, San Diego, La Jolla, CA.
Cancer Journal (Sudbury, Mass.)
|November 26, 2019
Summary
Targeted therapies for chronic lymphocytic leukemia (CLL) are advancing by understanding cancer biology, not just mutated oncogenes. Drugs targeting Bruton tyrosine kinase and BCL2 are effective, with ROR1 as a potential new target.
Area of Science:
- Oncology
- Hematology
- Molecular Biology
Background:
- Chronic lymphocytic leukemia (CLL) treatment advances leverage biological insights.
- CLL cell survival and proliferation depend on the tumor microenvironment.
- Key signaling pathways include B-cell receptor and chemokine signaling.
Purpose of the Study:
- To discuss advances in targeted therapy for CLL.
- To highlight novel therapeutic targets in CLL.
- To explore combination strategies for CLL treatment.
Main Methods:
- Analysis of CLL cell signaling pathways.
- Identification of key molecular targets.
- Review of clinically effective targeted drugs.
Main Results:
- Ibrutinib targeting Bruton tyrosine kinase is effective.
- Venetoclax targeting BCL2 is effective.
- ROR1 is identified as a potential therapeutic target.
Conclusions:
- Targeted therapies based on CLL biology are highly effective.
- Exploiting BCL2 is a successful therapeutic strategy.
- ROR1 presents a promising target for future CLL therapies, potentially in combination treatments.
Related Concept Videos
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:50Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K